VAI-SU2C Epigenetics Dream Team
11 results.
MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…
GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…
Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…
GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…
Four years ago, we embarked on a collaborative endeavor to improve cancer treatment by establishing the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics…
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…
GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…